LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Crucial Mitophagy Protein Identified

By LabMedica International staff writers
Posted on 05 Jan 2017
Image: Two mitochondria from mammalian lung tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
Image: Two mitochondria from mammalian lung tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
A receptor protein located on the inner mitochondrial membrane has been identified as a critical initiator of the process of mitochondrial destruction known as mitophagy.

The removal of unwanted or damaged mitochondria by the autophagic process known as mitophagy is essential for key events in development, cellular homeostasis, tumor suppression, and prevention of neurodegeneration and aging. However, the precise mechanisms of mitophagy have not been elucidated.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) unraveled some of the secrets of mitophagy and described their findings in the December 22, 2016, online edition of the journal Cell.

They reported that they had identified the inner mitochondrial membrane protein, prohibitin 2 (PHB2), as a crucial mitophagy receptor involved in targeting mitochondria for autophagic degradation. PHB2 is located on the inner membrane of mitochondria, but is exposed when a mitochondrion's outer membrane ruptures. Should this occur, the LC3 (Microtubule-associated proteins 1A/1B light chain 3A) protein, which is present on the exterior of autophagosomes binds to PHB2. The autophagosome then transports the damaged mitochondrion to be destroyed by a lysosome.

The investigators also found that PHB2 was required for mitophagy induced by Parkin protein in mammalian cells and for the clearance of paternal mitochondria after embryonic fertilization in the flatworm C. elegans.

"The removal of damaged mitochondria by autophagy (a process called mitophagy) is important for cellular health," said senior author Dr. Beth Levine, professor of internal medicine and microbiology at the University of Texas Southwestern Medical Center. "By understanding how cells get rid of damaged mitochondria that contribute to cancer, neurodegenerative diseases, and aging, we may be able to develop treatments to prevent those processes."

Related Links:
University of Texas Southwestern Medical Center

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more